HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J&J/McNeil Divests E.P.T. Pregnancy Tests To Insight Pharmaceuticals

This article was originally published in The Tan Sheet

Executive Summary

Johnson & Johnson divests another non-core consumer health brand – e.p.t. pregnancy tests – as the remediation of its OTC business continues.

You may also be interested in...

Insight Acquires Monistat In Third Deal With McNeil For Women’s OTC Drugs

Insight Pharmaceutical expanded its women’s health care footprint with the acquisition of the Monistat North American portfolio from McNeil Consumer Healthcare.

J&J Consumer Recaptures Growth, Plans To Restore Most OTCs By Mid-2012

Johnson & Johnson reported July 19 the first period of positive growth for its consumer unit in more than a year.

GlaxoSmithKline's OTC Garage Sale Includes alli, FiberChoice

GlaxoSmithKline includes the alli weight-loss brand in its planned divestment of international OTCs worth about $813 million in 2010 sales, or 10% of the firm's total Consumer Healthcare business.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts